1/25
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Hemophelia
Manifestations
may present as a mild, moderate or severe bleeding disorder
excessive bleeding with trauma or surgery
bleeding into soft tissues, muscles and joints
excessive menstrual bleeding
Treatment
avoidance of injury, prevention of bleeding
replacement therapy with recombinant clotting factors
Von Willebrand Disease
Manifestations
Most common hereditary bleeding disorder
A genetic lack of vWF | a reduction in platelet adhesion
Symptoms
Excessive bruising
Bleeding | mild to moderate
Occurence of bleeding | gums, nose, GI tract
Heavy blood flow | menstruation
Desmopressin Acetate
one of the treatments for von Willebrand disease
a vasopressin analog
Increases activity of factor VIII, stimulates production of vWF
Vitamin K
an essential factor for synthesis of factors II, VII, IX, and X by liver enzymes
Source: green leafy vegetables | through bacterial metabolism in the gut
Liver Disease
Site of synthesis of clotting factors: Liver
Any disease or condition that alters liver function may lead to defective production of clotting factors
Thrombocytopenia
any condition in which platelet count is abnormally low (<100,000 microL/blood)
Immune Thrombocytopenia Purpura
Occurence
children and adolescents following a viral infection
autoimmune disorder in which antibodies bind to platelets in circulation
Enlargement of spleen
Antiphospholipid Syndrome
Hypercoagulability caused by the formation of antibodies against negatively charged phospholipids
the abnormal antibodies that are produced appear to activate the coagulation cascades
Hypercoagulability
individuals with _______ are at increased risk for venous thrombus and emboli
Leiden Mutation
genetic defect in clotting factor V that makes it less susceptible to inactivation
affects 2%-5% of whites
Disseminated Intravascular Coagulation
A secondary condition that can occur as a result of overactivation of the intrinsic and extrinsic coagulation pathways
Characterization: Paradoxical of both inappropriate activation of the clotting cascades and the distruction of platelets
Anemia
a condition in which there is a reduced number of red blood cells or decreased concentration of hemoglobin in those cells or both
Hemolytic anemia
anemia that results from excess destruction of red blood cells (hemolysis)
Iron-deficiency anemia
major cause of anemia worldwide
Causes:
iron-deficient diets
poor absorption of iron from the intestine
persistent blood loss | ulcers, neoplasia
Cobalamin-deficiency or Folate deficiency anemia
Vitamin B12 and folic acid are essential nutrients required for DNA synthesis and red bloock cell maturation
Deficiency results to:
formation of abnormal shaped-red blood cells with shortened life spans due to weakened cell membranes
Sickle cell disease
is a group of autosomal recessive disorders characterized by abnormal hemoglobin production
Thalassemia
a genetic disorder characterized by absent or defective production of hemoglobin a or B chains
B thalassemia
defective formation of B hemoglobin chains
most common in individuals from Mediterranean populations
a Thalassemia
defective formation of alpha-hemoglobin chains
occurs mostly in asians
G6PD
an enzyme that helps protect red blood cells against hemolysis during periods of oxidative stress
found on the X-chromosome
G6PD Deficiency
a defective gene for G6PD | fully expressed in homozygous males | partially expressed in heterozygous females
most common in patients of Mediterranean or African-American descent
individuals are usally asymptomatic
Aplastic Anemia
caused by a lack of red blood cell production by the bone marrow
if erythrocyte stem cells precursors are lacking or destroyed, the process of erythropoeisis will be severely impaired
Polycythemia
is a disorder in which the number of red blood cells in circulation is greatly increased
Relative polycythemia
results from an increase in the concentration of red blood cells due to a loss of plasma volume
Primary polycythemia
polycythemia vera
caused by excessive proliferation of bone marrow stem cells
Secondary polycythemia
may occur from excess erythropoetin production as a physiologic response to hypoxia